Page last updated: 2024-08-24

plerixafor and Leukemia-Lymphoma, Adult T-Cell

plerixafor has been researched along with Leukemia-Lymphoma, Adult T-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ainai, A; Hall, WW; Hasegawa, H; Iha, H; Kawaguchi, A; Kimura, T; Ogata, M; Okamoto, T; Orba, Y; Sata, T; Sawa, H; Tsuji, T1

Other Studies

1 other study(ies) available for plerixafor and Leukemia-Lymphoma, Adult T-Cell

ArticleYear
Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice.
    Blood, 2009, Oct-01, Volume: 114, Issue:14

    Topics: Adult; Aged; Animals; Anti-HIV Agents; Benzylamines; Cell Movement; Cells, Cultured; Chemokine CXCL12; Cyclams; Female; Gene Products, tax; Heterocyclic Compounds; Human T-lymphotropic virus 1; Humans; Immunoblotting; Immunoenzyme Techniques; Leukemia-Lymphoma, Adult T-Cell; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Mice, Transgenic; Middle Aged; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2009